Cargando…

The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis

INTRODUCTION: Increased versican expression has been associated with local breast cancer invasiveness and a more aggressive tumor phenotype. The cellular mechanisms are not fully understood and this study evaluated versican G3 domain with its EGF-like motifs in influencing tumor invasion and metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Yee, Albert JM, Akens, Margarete, Yang, Bing L, Finkelstein, Joel, Zheng, Peng-Sheng, Deng, Zhaoqiong, Yang, Burton
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206723/
https://www.ncbi.nlm.nih.gov/pubmed/17662123
http://dx.doi.org/10.1186/bcr1751
_version_ 1782148498618056704
author Yee, Albert JM
Akens, Margarete
Yang, Bing L
Finkelstein, Joel
Zheng, Peng-Sheng
Deng, Zhaoqiong
Yang, Burton
author_facet Yee, Albert JM
Akens, Margarete
Yang, Bing L
Finkelstein, Joel
Zheng, Peng-Sheng
Deng, Zhaoqiong
Yang, Burton
author_sort Yee, Albert JM
collection PubMed
description INTRODUCTION: Increased versican expression has been associated with local breast cancer invasiveness and a more aggressive tumor phenotype. The cellular mechanisms are not fully understood and this study evaluated versican G3 domain with its EGF-like motifs in influencing tumor invasion and metastasis. METHODS: One recombinant construct was synthesized (a signal peptide for product secretion and the versican G3 domain). The construct was stably transfected into human breast carcinoma MT-1 cells. Cell viability in vitro was evaluated in low serum and serum starvation conditions. In vivo study of tumor growth was evaluated in a nude mouse model. G3 effects on rodent vascular endothelial cells were evaluated in vitro on cell survival, apoptosis, migration, and vascular formation. The effects of VEGF, fibronectin, and G3 on vascular formation were examined. An intracardiac injection model of metastatic human breast carcinoma tested the effect of G3 on distant bony and soft tissue metastasis. Analysis of metastatic burden included histology, radiographs, and micro-CT quantification of osteolysis. RESULTS: A greater viability of cancer cells was observed in low serum and serum-free conditions in the presence of versican G3. Larger subcutaneous tumors were obtained in the G3 group following tumor cell injection into CD1 mice. G3 induced a greater degree of rodent vascular endothelial cell proliferation and migration in vitro. Simultaneous presence of fibronectin, VEGF, and G3 promoted endothelial cell migration in wound-healing assays as compared to the treatments containing none, one or two of these molecules. Systemic tumor burden to distant bony and soft tissue metastatic sites was greater in the G3 group using the intracardiac injection metastatic model CONCLUSION: Versican G3 domain appears to be important in local and systemic tumor invasiveness of human breast cancer. Effects include enhancing cell viability, proliferation, migration and enhancing local tumor growth. Potential effects on angiogenesis include enhancing vascular endothelial proliferation, migration, and vessel formation. The interactions between tumor cells, surrounding stromal components and neo-vascularization in breast cancer may include interactions with VEGF and fibronectin. The propensity of versican G3 to influence tumor invasion to bone and the mechanisms of G3 mediated osteolysis warrants ongoing studies.
format Text
id pubmed-2206723
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22067232008-01-19 The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis Yee, Albert JM Akens, Margarete Yang, Bing L Finkelstein, Joel Zheng, Peng-Sheng Deng, Zhaoqiong Yang, Burton Breast Cancer Res Research Article INTRODUCTION: Increased versican expression has been associated with local breast cancer invasiveness and a more aggressive tumor phenotype. The cellular mechanisms are not fully understood and this study evaluated versican G3 domain with its EGF-like motifs in influencing tumor invasion and metastasis. METHODS: One recombinant construct was synthesized (a signal peptide for product secretion and the versican G3 domain). The construct was stably transfected into human breast carcinoma MT-1 cells. Cell viability in vitro was evaluated in low serum and serum starvation conditions. In vivo study of tumor growth was evaluated in a nude mouse model. G3 effects on rodent vascular endothelial cells were evaluated in vitro on cell survival, apoptosis, migration, and vascular formation. The effects of VEGF, fibronectin, and G3 on vascular formation were examined. An intracardiac injection model of metastatic human breast carcinoma tested the effect of G3 on distant bony and soft tissue metastasis. Analysis of metastatic burden included histology, radiographs, and micro-CT quantification of osteolysis. RESULTS: A greater viability of cancer cells was observed in low serum and serum-free conditions in the presence of versican G3. Larger subcutaneous tumors were obtained in the G3 group following tumor cell injection into CD1 mice. G3 induced a greater degree of rodent vascular endothelial cell proliferation and migration in vitro. Simultaneous presence of fibronectin, VEGF, and G3 promoted endothelial cell migration in wound-healing assays as compared to the treatments containing none, one or two of these molecules. Systemic tumor burden to distant bony and soft tissue metastatic sites was greater in the G3 group using the intracardiac injection metastatic model CONCLUSION: Versican G3 domain appears to be important in local and systemic tumor invasiveness of human breast cancer. Effects include enhancing cell viability, proliferation, migration and enhancing local tumor growth. Potential effects on angiogenesis include enhancing vascular endothelial proliferation, migration, and vessel formation. The interactions between tumor cells, surrounding stromal components and neo-vascularization in breast cancer may include interactions with VEGF and fibronectin. The propensity of versican G3 to influence tumor invasion to bone and the mechanisms of G3 mediated osteolysis warrants ongoing studies. BioMed Central 2007 2007-07-27 /pmc/articles/PMC2206723/ /pubmed/17662123 http://dx.doi.org/10.1186/bcr1751 Text en Copyright © 2007 Yee et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yee, Albert JM
Akens, Margarete
Yang, Bing L
Finkelstein, Joel
Zheng, Peng-Sheng
Deng, Zhaoqiong
Yang, Burton
The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
title The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
title_full The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
title_fullStr The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
title_full_unstemmed The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
title_short The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis
title_sort effect of versican g3 domain on local breast cancer invasiveness and bony metastasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206723/
https://www.ncbi.nlm.nih.gov/pubmed/17662123
http://dx.doi.org/10.1186/bcr1751
work_keys_str_mv AT yeealbertjm theeffectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT akensmargarete theeffectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT yangbingl theeffectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT finkelsteinjoel theeffectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT zhengpengsheng theeffectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT dengzhaoqiong theeffectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT yangburton theeffectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT yeealbertjm effectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT akensmargarete effectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT yangbingl effectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT finkelsteinjoel effectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT zhengpengsheng effectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT dengzhaoqiong effectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis
AT yangburton effectofversicang3domainonlocalbreastcancerinvasivenessandbonymetastasis